{"id":166509,"date":"2025-01-24T11:14:20","date_gmt":"2025-01-24T16:14:20","guid":{"rendered":"https:\/\/44.250.171.167\/?p=166509"},"modified":"2025-01-24T11:14:20","modified_gmt":"2025-01-24T16:14:20","slug":"torrent-pharmaceuticals-ltd-q3fy25-14-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q3fy25-14-rise-in-profits\/","title":{"rendered":"Torrent Pharmaceuticals Ltd Q3FY25; 14% rise in Profits"},"content":{"rendered":"<p>Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.<\/p>\n<h2>\nFinancial Results:<\/h2>\n<p>Torrent Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b92,809.00 Crores up from \u20b92,732.00 Crore year on year, a rise of 2.82%.<\/p>\n<p>Total Expenses for Q3FY25 of \u20b92,151.00 Crores down from \u20b92,156.00 Crores year on year, a fall of 0.23%.<\/p>\n<p>Consolidated Net Profit of \u20b9503.00 Crores up 13.54% from \u20b9443.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b914.86, up 13.52% from \u20b913.09 in the same quarter of the previous year.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-166511\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704-849x1024.png\" alt=\"\" width=\"640\" height=\"772\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704-849x1024.png 849w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704-249x300.png 249w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704-768x926.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704-1274x1536.png 1274w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704-1699x2048.png 1699w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b92,809.00 Crores up from \u20b92,732.00 Crore year on year, a rise of 2.82%. Total Expenses for Q3FY25 of \u20b92,151.00 Crores down from \u20b92,156.00 [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":166511,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[11776,8157,10162],"class_list":["post-166509","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-active-pharmaceutical-ingredients","tag-healthcare","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/a4015346-c746-4ecb-8769-d2f4c3bc4704.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":166709,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-ltd-q3fy25-88-rise-in-profits\/","url_meta":{"origin":166509,"position":0},"title":"Glenmark Pharmaceuticals Ltd Q3FY25; 88% rise in Profits","author":"Divyansh_Kasana","date":"February 6, 2025","format":false,"excerpt":"Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries. Financial Results: Capri Global Capital Ltd reported Revenues for Q3FY25 of \u20b9821.00 Crores up from \u20b9605.00 Crore year on year, a rise of 35.7%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/U-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/U-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/U-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/U-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/U-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/U-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167021,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q3fy25-23-fall-in-profits\/","url_meta":{"origin":166509,"position":1},"title":"Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits","author":"Divyansh_Kasana","date":"February 21, 2025","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b91,693.00 Crores up from \u20b91,631.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166559,"url":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-industries-ltd-q3fy25-14-rise-in-profits\/","url_meta":{"origin":166509,"position":2},"title":"Sun Pharmaceuticals Industries Ltd Q3FY25; 14% rise in Profits","author":"Chirag Gupta","date":"January 31, 2025","format":false,"excerpt":"Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/59e6ac9a-3a7e-4723-a8fb-c70767998ed4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167555,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q3fy25-77-rise-in-profits\/","url_meta":{"origin":166509,"position":3},"title":"Suven Pharmaceuticals Ltd Q3FY25; 77% rise in Profits","author":"Chirag Gupta","date":"March 25, 2025","format":false,"excerpt":"Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations. Financial Results: Suven Pharmaceuticals Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/4-13.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167751,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q3fy25-400-rise-in-profits\/","url_meta":{"origin":166509,"position":4},"title":"Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits","author":"Divyansh_Kasana","date":"April 4, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b9949.00 Crores up from \u20b9805.00 Crore year on year, a rise of 17.89%. Total Expenses for Q3FY25 of \u20b9677.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166692,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-ltd-q3fy25-16-fall-in-profits\/","url_meta":{"origin":166509,"position":5},"title":"Glenmark Pharmaceuticals Ltd Q3FY25; 16% fall in Profits","author":"Divyansh_Kasana","date":"February 5, 2025","format":false,"excerpt":"Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries. Financial Results: Glenmark Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b91,926.00 Crores up from \u20b92,507.00 Crore year on year, a rise of 5.77%. Total Expenses for Q3FY25\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/166509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=166509"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/166509\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/166511"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=166509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=166509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=166509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}